Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
Cancer Gene Therapy|August 29, 2003
Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cellsSandra Tuyaerts, Annelies Michiels, Jurgen Corthals, et al.Journal of Immunological Methods|August 23, 2002
Generation of large numbers of dendritic cells in a closed system using Cell FactoriesSandra Tuyaerts, Sofie M Noppe, Jurgen Corthals, et al.Vaccines|November 13, 2020
Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical TrialJulia Katharina Schwarze, Gil Awada, Louise Cras, et al.Journal of Leukocyte Biology|April 24, 2007
Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cellsSandra Tuyaerts, Sonja Van Meirvenne, Aude Bonehill, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II moleculesAude Bonehill, Carlo Heirman, Sandra Tuyaerts, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2008
Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNAAude Bonehill, Sandra Tuyaerts, An M T Van Nuffel, et al.Journal of Translational Medicine|June 25, 2014
Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlationsMutsa T Madondo, Sandra Tuyaerts, Brit B Turnbull, et al.Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70)An Coosemans, Sandra Tuyaerts, Kim Morias, et al.Vaccines|May 26, 2026
Reinvigorating the Cancer-Immunity Cycle by Intratumoral Administration of Conventional Dendritic Cells in Melanoma and Other Solid Tumors: A Narrative ReviewManon Vounckx, Iris Dirven, Cleo Bertels, et al.Molecular Therapy. Oncology|September 16, 2025
Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell deathSandra Tuyaerts, Xenia Geeraerts, Alberto Reale, et al.Pageof 6